Federal Register of Legislation - Australian Government

Primary content

PB 90 of 2021 Determinations/Health as made
This instrument amends the National Health (Continued Dispensing – Emergency Measures) Determination 2020 to make changes to the pharmaceutical benefits eligible to be provided as a Continued Dispensing supply.
Administered by: Health
Registered 31 Aug 2021
Tabling HistoryDate
Tabled HR31-Aug-2021
Tabled Senate01-Sep-2021
To be repealed 10 Feb 2022
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Table of contents.

Commonwealth Coat of Arms of Australia

 

PB 90 of 2021

 

National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2021 (No. 8)

I, NIKOLAI TSYGANOV, Assistant Secretary (Acting), Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, and delegate of the Minister for Health and Aged Care, make the following determination.

Dated               27 August 2021

 

 

 

 

NIKOLAI TSYGANOV

Assistant Secretary (Acting)

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 

 

 

 

 

 

                                           


 

 

Contents

1           Name…………………………………………………………………………….………………1

2.......... Commencement............................................................................................................................ 1

3.......... Authority...................................................................................................................................... 1

4 ......... Schedule....................................................................................................................................... 1

Schedule 1—Amendments                                                                                                                          2

National Health (Continued Dispensing - Emergency Measures) Determination 2020         2

 

 

 


1     Name

(1)      This instrument is the National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2021 (No. 8).

(2)      This instrument may also be cited as PB 90 of 2021.

2     Commencement

(1)          Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 September 2021

1 September 2021

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2)          Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3     Authority

This instrument is made under subsection 89A(3) of the National Health Act 1953.

4     Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.


Schedule 1Amendments

National Health (Continued Dispensing – Emergency Measures) Determination 2020

[1]        Schedule 1, after entry for Adrenaline (epinephrine) in the form I.M. injection 300 micrograms in 0.3 mL single dose syringe auto-injector  

insert:

 

I.M. injection 500 micrograms in 0.3 mL single dose syringe auto-injector

Injection

[2]        Schedule 1, after entry for Amino acid formula with fat, carbohydrate, vitamins, minerals, trace elements and medium chain triglycerides in the form Oral powder 400 g (Neocate Junior)

insert:

 

Oral powder 800 g (Essential Care Jr)

Oral

[3]        Schedule 1, after entry for Carbomer 974

insert:

Cariprazine

Capsule 1.5 mg

Oral

 

Capsule 3 mg

Oral

 

Capsule 4.5 mg

Oral

 

Capsule 6 mg

Oral

[4]        Schedule 1, entry for Diazepam

(a)        omit:

 

Oral liquid 1 mg in 1 mL, 100 mL

Oral

(b)        insert as first entry:

 

Oral liquid 10 mg per 10 mL, 100 mL

Oral

[5]        Schedule 1, entry for Fluoxetine

omit:

 

Capsule 20 mg (as hydrochloride) (USP)

Oral

[6]        Schedule 1, entry for High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate

omit from the column headed “Form”: Oral semi-solid 100 g, 48 (Keyo)           substitute: Oral semi-solid 100 g, 36 (K.Yo)

[7]        Schedule 1, entry for Metformin

omit:

 

Tablet (prolonged release) containing metformin hydrochloride 500 mg

Oral

[8]        Schedule 1, after entry for Nystatin in the form Tablet 500,000 units

insert:

Obeticholic acid

Tablet 5 mg

Oral

 

Tablet 10 mg

Oral

[9]        Schedule 1, entry for Olaparib

omit:

 

Capsule 50 mg

Oral

[10]      Schedule 1, after entry for Prednisolone in the form Tablet 5 mg

insert:

Prednisolone acetate

Eye drops containing prednisolone acetate 10 mg per mL, 10 mL

Application to the eye

[11]      Schedule 1, entry for Trihexyphenidyl

omit:

 

Tablet containing trihexyphenidyl hydrochloride 2 mg (USP)

Oral

[12]      Schedule 1, after entry for Varenicline in the form Tablet 1 mg (as tartrate)

insert:

Vedolizumab

Injection 108 mg in 0.68 mL single use pre-filled pen

Injection